{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:32:52Z","timestamp":1740184372846,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["21H02721","18K16269"],"award-info":[{"award-number":["21H02721","18K16269"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"name":"translational research program from Fukushima Prefecture"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-024-01732-4","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T03:31:31Z","timestamp":1735011091000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nuclear receptor profiling for subtype classification and as prognostic markers in 33 cancer types"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9794-590X","authenticated-orcid":false,"given":"Kazuya","family":"Nakamichi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6291-4217","authenticated-orcid":false,"given":"Hironori","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5262-8479","authenticated-orcid":false,"given":"Yusuke","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7507-8214","authenticated-orcid":false,"given":"Kentaro","family":"Semba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8844-4295","authenticated-orcid":false,"given":"Jun","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,24]]},"reference":[{"issue":"4","key":"1732_CR1","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1124\/pr.58.4.2","volume":"58","author":"P Germain","year":"2006","unstructured":"Germain P, Staels B, Dacquet C, Spedding M, Laudet V. Overview of nomenclature of nuclear receptors. Pharmacol Rev. 2006;58(4):685\u2013704. https:\/\/doi.org\/10.1124\/pr.58.4.2.","journal-title":"Pharmacol Rev"},{"key":"1732_CR2","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s000180050043","volume":"57","author":"GI Owen","year":"2000","unstructured":"Owen GI, Zelent A. Origins and evolutionary diversification of the nuclear receptor superfamily. Cell Mol Life Sci. 2000;57:809\u201327. https:\/\/doi.org\/10.1007\/s000180050043.","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"1732_CR3","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-x","volume":"83","author":"DJ Mangelsdorf","year":"1995","unstructured":"Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade. Cell. 1995;83(6):835\u20139. https:\/\/doi.org\/10.1016\/0092-8674(95)90199-x.","journal-title":"Cell"},{"issue":"6","key":"1732_CR4","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.trecan.2020.11.007","volume":"7","author":"Z Yang","year":"2021","unstructured":"Yang Z, Gimple RC, Zhou N, Zhao L, Gustafsson J\u00c5, Zhou S. Targeting nuclear receptors for cancer therapy: premises, promises, and challenges. Trends in Cancer. 2021;7(6):541\u201356. https:\/\/doi.org\/10.1016\/j.trecan.2020.11.007.","journal-title":"Trends in Cancer"},{"key":"1732_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286\u2013287","author":"D Sonkin","year":"2024","unstructured":"Sonkin D, Thomas A, Teicher BA. Cancer treatments: past, present, and future. Cancer Genet. 2024;286\u2013287:18\u201324. https:\/\/doi.org\/10.1016\/j.cancergen.2024.06.002.","journal-title":"Cancer Genet"},{"key":"1732_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"Cancer Genome Atlas Network","year":"2012","unstructured":"Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490:61\u201370. https:\/\/doi.org\/10.1038\/nature11412.","journal-title":"Nature"},{"key":"1732_CR7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1023\/a:1006132427948","volume":"51","author":"CK Osborne","year":"1998","unstructured":"Osborne CK. Steroid hormone receptors in breast cancer management. Breast Cancer Res Treat. 1998;51:227\u201338. https:\/\/doi.org\/10.1023\/a:1006132427948.","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"1732_CR8","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nrclinonc.2014.72","volume":"11","author":"YNS Wong","year":"2014","unstructured":"Wong YNS, Ferraldeschi R, Attard G, De Bono J. Evolution of androgen receptor targeted therapy for advanced prostate cancer. Nat Rev Clin Oncol. 2014;11(6):365\u201376. https:\/\/doi.org\/10.1038\/nrclinonc.2014.72.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"1732_CR9","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1210\/endrev\/bnab002","volume":"42","author":"K Desai","year":"2021","unstructured":"Desai K, McManus JM, Sharifi N. Hormonal therapy for prostate cancer. Endocr Rev. 2021;42(3):354\u201373. https:\/\/doi.org\/10.1210\/endrev\/bnab002.","journal-title":"Endocr Rev"},{"issue":"10","key":"1732_CR10","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/sj.leu.2402721","volume":"16","author":"D Grimwade","year":"2002","unstructured":"Grimwade D, Lo CF. Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia. Leukemia. 2002;16(10):1959\u201373. https:\/\/doi.org\/10.1038\/sj.leu.2402721.","journal-title":"Leukemia"},{"issue":"6","key":"1732_CR11","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1182\/blood.V57.6.1000.1000","volume":"57","author":"TR Breitman","year":"1981","unstructured":"Breitman TR, Collins SJ, Keene BR. Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid. Blood. 1981;57(6):1000\u20134. https:\/\/doi.org\/10.1182\/blood.V57.6.1000.1000.","journal-title":"Blood"},{"issue":"6","key":"1732_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41408-021-00514-3","volume":"11","author":"M Yilmaz","year":"2021","unstructured":"Yilmaz M, Kantarjian H, Ravandi F. Acute promyelocytic leukemia current treatment algorithms. Blood cancer J. 2021;11(6):123. https:\/\/doi.org\/10.1038\/s41408-021-00514-3.","journal-title":"Blood cancer J"},{"issue":"6","key":"1732_CR13","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1124\/pharmrev.121.000436","volume":"75","author":"TP Burris","year":"2023","unstructured":"Burris TP, de Vera IMS, Cote I, et al. International union of basic and clinical pharmacology CXIII: Nuclear receptor superfamily\u2014Update 2023. Pharmacol Rev. 2023;75(6):1233\u2013318. https:\/\/doi.org\/10.1124\/pharmrev.121.000436.","journal-title":"Pharmacol Rev"},{"issue":"2","key":"1732_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","volume":"173","author":"KA Hoadley","year":"2018","unstructured":"Hoadley KA, Yau C, Hinoue T, et al. Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer. Cell. 2018;173(2):291\u2013304. https:\/\/doi.org\/10.1016\/j.cell.2018.03.022.","journal-title":"Cell"},{"key":"1732_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cancergen.2023.10.001","volume":"278","author":"H Liu","year":"2023","unstructured":"Liu H, Tang T. Pan-cancer genetic analysis of disulfidptosis-related gene set. Cancer Genet. 2023;278:91\u2013103. https:\/\/doi.org\/10.1016\/j.cancergen.2023.10.001.","journal-title":"Cancer Genet"},{"issue":"5","key":"1732_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134. https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0095.","journal-title":"Cancer Discov"},{"issue":"23","key":"1732_CR17","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1158\/0008-5472.CAN-23-0816","volume":"83","author":"I de Bruijn","year":"2023","unstructured":"de Bruijn I, Kundra R, Mastrogiacomo B, et al. Analysis and visualization of longitudinal genomic and clinical data from the AACR project GENIE biopharma collaborative in cBioPortal. Cancer Res. 2023;83(23):3861\u20137. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-0816.","journal-title":"Cancer Res"},{"issue":"269","key":"1732_CR18","doi-asserted-by":"publisher","first-page":"l1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):l1. https:\/\/doi.org\/10.1126\/scisignal.2004088.","journal-title":"Sci Signal"},{"issue":"301","key":"1732_CR19","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1080\/01621459.1963.10500845","volume":"58","author":"JH Ward Jr","year":"1963","unstructured":"Ward JH Jr. Hierarchical grouping to optimize an objective function. J Am Stat Assoc. 1963;58(301):236\u201344.","journal-title":"J Am Stat Assoc"},{"issue":"2","key":"1732_CR20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/gtc.13092","volume":"29","author":"N Nakamichi","year":"2024","unstructured":"Nakamichi N, Yamamoto Y, Semba K. Nakayama J Metastatic potentials classified with hypoxia-inducible factor 1 downstream genes in pan-cancer cell lines. Genes Cells. 2024;29(2):169\u201377. https:\/\/doi.org\/10.1111\/gtc.13092.","journal-title":"Genes Cells"},{"key":"1732_CR21","unstructured":"Konopka T. 2023. https:\/\/CRAN.R-project.org\/package=umap. Accessed 5 July 2024."},{"key":"1732_CR22","unstructured":"R Core Team. 2023. https:\/\/www.r-project.org\/. Accessed 5 July 2024."},{"key":"1732_CR23","unstructured":"Therneau T. 2024. https:\/\/CRAN.R-project.org\/package=survival. Accessed 5 July 2024."},{"key":"1732_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"_Modeling survival data: extending the cox model_","author":"TM Therneau","year":"2000","unstructured":"Therneau TM, Grambsch PM. _Modeling survival data: extending the cox model_. New York: Springer; 2000."},{"key":"1732_CR25","unstructured":"Kolde R. 2019. https:\/\/CRAN.R-project.org\/package=pheatmap. Accessed 5 July 2024."},{"key":"1732_CR26","unstructured":"Daniel Adler, S. Thomas Kelly, Tom Elliott, and Jordan Adamson (2022). vioplot: violin plot. R package\nversion 0.4.0. https:\/\/github.com\/TomKellyGenetics\/vioplot. Accessed 5 July 2024."},{"issue":"2","key":"1732_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1365-2443.2010.01473.x","volume":"16","author":"K Taguchi","year":"2011","unstructured":"Taguchi K, Motohashi H, Yamamoto M. Molecular mechanisms of the Keap1\u2013Nrf2 pathway in stress response and cancer evolution. Genes Cells. 2011;16(2):123\u201340. https:\/\/doi.org\/10.1111\/j.1365-2443.2010.01473.x.","journal-title":"Genes Cells"},{"issue":"6","key":"1732_CR28","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.jtho.2022.03.011","volume":"17","author":"S Scalera","year":"2022","unstructured":"Scalera S, Mazzotta M, Cortile C, et al. KEAP1-Mutant NSCLC: the catastrophic failure of a cell-protecting hub. J Thorac Oncol. 2022;17(6):751\u20137. https:\/\/doi.org\/10.1016\/j.jtho.2022.03.011.","journal-title":"J Thorac Oncol"},{"key":"1732_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/PO.18.00307","volume":"3","author":"R Shen","year":"2019","unstructured":"Shen R, Martin A, Ni A, et al. Harnessing clinical sequencing data for survival stratification of patients with metastatic lung adenocarcinomas. JCO Precis Oncol. 2019;3:1\u20139. https:\/\/doi.org\/10.1200\/PO.18.00307.","journal-title":"JCO Precis Oncol"},{"issue":"3","key":"1732_CR30","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1158\/1078-0432.CCR-20-1985","volume":"27","author":"A Singh","year":"2021","unstructured":"Singh A, Daemen A, Nickles D, et al. NRF2 activation promotes aggressive lung cancer and associates with poor clinical outcomes. Clin Cancer Res. 2021;27(3):877\u201388. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-1985.","journal-title":"Clin Cancer Res"},{"issue":"45","key":"1732_CR31","doi-asserted-by":"publisher","first-page":"4768","DOI":"10.1038\/onc.2011.628","volume":"31","author":"T Yamadori","year":"2012","unstructured":"Yamadori T, Ishii Y, Homma S, et al. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers. Oncogene. 2012;31(45):4768\u201377. https:\/\/doi.org\/10.1038\/onc.2011.628.","journal-title":"Oncogene"},{"issue":"11","key":"1732_CR32","first-page":"5174","volume":"13","author":"XY Zhang","year":"2023","unstructured":"Zhang XY, Zhang H, Hu SJ, et al. NR0B1 suppresses ferroptosis through upregulation of NRF2\/c-JUN-CBS signaling pathway in lung cancer cells. Am J Cancer Res. 2023;13(11):5174.","journal-title":"Am J Cancer Res"},{"key":"1732_CR33","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.freeradbiomed.2016.12.041","volume":"103","author":"K Tsuchida","year":"2017","unstructured":"Tsuchida K, Tsujita T, Hayashi M, et al. Halofuginone enhances the chemo-sensitivity of cancer cells by suppressing NRF2 accumulation. Free Radic Biol Med. 2017;103:236\u201347. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.12.041.","journal-title":"Free Radic Biol Med"},{"issue":"16","key":"1732_CR34","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1158\/0008-5472.CAN-19-2888","volume":"80","author":"M Hayashi","year":"2020","unstructured":"Hayashi M, Kuga A, Suzuki M, et al. Microenvironmental activation of Nrf2 restricts the progression of Nrf2-activated malignant tumors. Cancer Res. 2020;80(16):3331\u201344. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-2888.","journal-title":"Cancer Res"},{"issue":"3","key":"1732_CR35","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.cell.2017.08.051","volume":"171","author":"L Bar-Peled","year":"2017","unstructured":"Bar-Peled L, Kemper EK, Suciu RM, et al. Chemical proteomics identifies druggable vulnerabilities in a genetically defined cancer. Cell. 2017;171(3):696\u2013709. https:\/\/doi.org\/10.1016\/j.cell.2017.08.051.","journal-title":"Cell"},{"issue":"1","key":"1732_CR36","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1038\/s41467-017-01877-7","volume":"8","author":"S Peri","year":"2017","unstructured":"Peri S, Izumchenko E, Schubert AD, et al. NSD1-and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis. Nat Commun. 2017;8(1):1772. https:\/\/doi.org\/10.1038\/s41467-017-01877-7.","journal-title":"Nat Commun"},{"issue":"1","key":"1732_CR37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41420-024-01842-6","volume":"10","author":"I Topchu","year":"2024","unstructured":"Topchu I, Bychkov I, Gursel D, Makhov P, Boumber Y. NSD1 supports cell growth and regulates autophagy in HPV-negative head and neck squamous cell carcinoma. Cell Death Discov. 2024;10(1):75. https:\/\/doi.org\/10.1038\/s41420-024-01842-6.","journal-title":"Cell Death Discov"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-024-01732-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-024-01732-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-024-01732-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T05:47:09Z","timestamp":1735019229000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-024-01732-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,24]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1732"],"URL":"https:\/\/doi.org\/10.1007\/s12672-024-01732-4","relation":{},"ISSN":["2730-6011"],"issn-type":[{"type":"electronic","value":"2730-6011"}],"subject":[],"published":{"date-parts":[[2024,12,24]]},"assertion":[{"value":"5 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"834"}}